| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.086 | 0.1 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.068 | 0.1 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |